Table 3.
Primary and Secondary Outcomes
| Outcome, n (%) |
Inhaled Nitric Oxide (n=6) |
Placebo (n=6) |
p Value |
|---|---|---|---|
| Death or BPD | 3/6 (50) | 6/6 (100) | 0.18 |
| Death | 2/6 (33) | 4/6 (67) | 0.57 |
| BPD* | 2/5 (40) | 2/2 (100) | 0.43 |
| Grade 3 or 4 IVH or PVL† | 1/5 (20) | 1/2 (50) | 0.46 |
This outcome is for infants who survived to 36 weeks’ post-menstrual age (five in iNO group and two in control group).
This outcome is for infants who survived to 28 days of life (five in iNO group and two in control group).